This is the text extract for February Tender Notification, browse documents here.

---

26 February 2010

TENDER RESULTS

The PHARMAC Board (or Chief Executive under delegated authority) has resolved to accept tenders for Sole Subsidised Supply and Hospital Supply Status for some of the products included in the Invitation to Tender dated 21 December 2007 and the Invitation to Tender dated 4 December 2009. Some of the pharmaceuticals that will be delisted when the period of sole supply commences may be subject to existing listing contracts with PHARMAC. Suppliers of pharmaceuticals that are subject to such contracts should continue to supply their pharmaceuticals under those contracts until such time as the pharmaceuticals are delisted and PHARMAC will continue to subsidise their pharmaceuticals accordingly. Product Notification Forms Please note that for all changes (price change, pack size change, new listing etc) to be effective in the Pharmaceutical Schedule (including Section H) suppliers are required to notify PHARMAC and the Guild by 4pm 12th March 2010. More information and product notification forms can be downloaded from our website – www.pharmac.govt.nz/schedule.asp. 2007/08 Tender Community pharmaceutical tenders – Section B of the Pharmaceutical Schedule 1. Tenders awarded to pharmaceuticals where at least one other brand is listed – listing for tender winning brand at the tender subsidy will occur on 1 April 2010, reference pricing of non-tender winning brand will occur on 1 June 2010 and Sole Subsidised Supply commences on 1 September 2010.

The decisions were as follows:

Chemical Name Docusate sodium Docusate sodium

Presentation; Pack size and type Tab 50 mg; 100 tablets, bottle Tab 120 mg; 100 tablets, bottle

Current New Subsidy tender and price subsidy $4.89 $6.73 $3.95 $5.49

Sole supply brand (Supplier) Laxofast 50 (Arrow) Laxofast 120 (Arrow)

Brands affected by reference pricing and delisting Coloxyl (Sigma) Coloxyl (Sigma)

Hospital pharmaceutical tenders – Section H of the Pharmaceutical Schedule 2. Tenders awarded to pharmaceuticals where no brand is listed - listing of the hospital tender winning brand of the pharmaceutical will occur in Section H of the Pharmaceutical Schedule on 1 April 2010 and DV Limits and DV Pharmaceuticals will apply from 1 June 2010.

The decisions were as follows:

Chemical Name Docusate sodium Docusate sodium

Presentation; Pack size and type Tab 50 mg; 100 tablets, bottle Tab 120 mg; 100 tablets, bottle

Hospital Supply Brand (Supplier) Laxofast 50 (Arrow) Laxofast 120 (Arrow)

Pack Price $3.95 $5.49

DV Limit 1% 1%

DV Pharmaceuticals Brand Name (Supplier) Coloxyl (Sigma) Coloxyl (Sigma)

2009/10 Tender Community pharmaceutical tenders – Section B of the Pharmaceutical Schedule 3. Tenders awarded to listed pharmaceuticals where no other brand is listed – subsidy changes on 1 April 2010 and Sole Supply Status commences 1 July 2010.

The decisions were as follows:

A324089 - qA12214

---

Chemical Name Dihydrocodeine tartrate

Presentation; Pack size and type Tab long-acting 60 mg; 60 tablets, bottle

Current Subsidy $30.30 $7.98 $49.14 $290.00 $58.00

New tender subsidy $27.27 $6.38 $32.92 $145.00 $29.00

Sole supply brand (Supplier) DHC Continus (MundiPharma) Laxsol (Sigma) Cyklokapron (Pfizer) Retrovir (GSK NZ) Retrovir (GSK NZ)

Docusate sodium with Tab 50 mg with total sennosides 8 mg; 200 sennosides tablets, bottle Tranexamic acid Zidovudine (AZT) Zidovudine (AZT) Tab 500 mg; 100 tablets, bottle Cap 100 mg; 100 tablets, bottle Oral liq 10 mg per ml; 200 ml OP, bottle

Hospital pharmaceutical tenders – Section H of the Pharmaceutical Schedule 4. Tenders awarded to listed pharmaceuticals where only the current brand is listed – price changes for hospital tender winning brands of the pharmaceuticals will occur in Section H of the Pharmaceutical Schedule on 1 April 2010; DV Limits and DV Pharmaceuticals will apply from 1 June 2010

The decisions were as follows:

Chemical Name

Presentation; Pack size and type

Hospital Supply Brand (Supplier)

Pack Price

DV Limit

DV Pharmaceuticals Brand Name (Supplier) Ciproxin (Bayer) DBL (Hospira) DP-Cipro (Douglas) Topistin (AFT) Ufexil (Multichem) Coloxy with Senna (Arrow) (B)

Ciprofloxacin

Inj 2 mg per ml, 100 ml; 10 injections, Aspen Ciprofloxacin bag (Aspen)

$41.00

1%

Docusate sodium with sennosides Tranexamic acid

Tab 50 mg with total sennosides 8 mg; 200 tablet, bottle Tab 500 mg; 100 tablets, bottle

Laxsol (Sigma) Cyklokapron (Pfizer)

$6.38 $32.92

1% 1%

5. Tenders awarded to pharmaceuticals where no brand is listed - listing of the hospital tender winning brand of the pharmaceutical will occur in Section H of the Pharmaceutical Schedule on 1 April 2010 and DV Limits and DV Pharmaceuticals will apply from 1 June 2010.

The decisions were as follows:

Chemical Name Dihydrocodeine tartrate Piperacillin sodium with tazobactam sodium Zidovudine (AZT) Zidovudine (AZT)

Presentation; Pack size and type Tab long-acting 60 mg; 60 tablets, bottle Inj 4 g with tazobactam sodium 500 mg; 1 injection, vial Cap 100 mg; 100 tablets, bottle Oral liq 10 mg per ml; 200 ml, bottle

Hospital Supply Brand (Supplier) DHC Continus (MundiPharma) Tazocin EF (Wyeth) Retrovir (GSK NZ) Retrovir (GSK NZ)

Pack Price $27.27 $12.00 $145.00 $29.00

DV Limit 1% 1% 1% 1%

DV Pharmaceuticals Brand Name (Supplier) (B) DBL (Hospira) Zobacin (Mylan) (B) (B)

For the remaining products on the Invitation to Tender dated 21 December 2007, the Invitation to Tender dated 23 December 2008 and the Invitation to Tender dated 4 December 2009 where no announcement has been made, either a decision is still pending, or is provisional and subject to the product gaining market approval and having sufficient stock. We will keep you informed regarding any changes for the remaining tender products as further decisions are made. If you have any queries regarding this notification please contact PHARMAC on 0800 66 00 50.

A324089 - qA12214

Page 2 of 2